Common use of Authorized and Outstanding Capital Stock Clause in Contracts

Authorized and Outstanding Capital Stock. As of the date hereof, the authorized capital stock of the Company consists of (A) 300,000,000 shares of Common Stock, of which, 46,383,143 are issued and outstanding and (B) 50,000,000 shares of Preferred Stock, none of which are issued and outstanding.

Appears in 3 contracts

Samples: Securities Purchase Agreement (Near Intelligence, Inc.), Securities Purchase Agreement (Near Intelligence, Inc.), Securities Purchase Agreement (Near Intelligence, Inc.)

AutoNDA by SimpleDocs

Authorized and Outstanding Capital Stock. As of the date hereof, the The Company’s authorized capital stock of the Company consists of (A) 300,000,000 100,000,000 shares of Common Stockcommon stock, $0.001 par value per share; and, as at the Reference Date (as hereinafter defined) there were <> of which, 46,383,143 are common stock issued and outstanding and (B) 50,000,000 no shares of Preferred Stock, none preferred stock issued and outstanding. If all of which the Offered Shares are sold there will be an aggregate of <> shares issued and outstanding.

Appears in 3 contracts

Samples: Subscription Agreement (Aurora Gold Corp), Subscription Agreement (Aurora Gold Corp), Subscription Agreement (Aurora Gold Corp)

Authorized and Outstanding Capital Stock. As of the date hereof, the authorized capital stock of the Company consists of (A) 300,000,000 750,000,000 shares of Common Stock, of which, 46,383,143 are issued and outstanding and (B) 50,000,000 shares of Preferred Stock, none of which are issued and outstanding. No shares of Common Stock are held in the treasury of the Company.

Appears in 3 contracts

Samples: Exchange Agreement (ShiftPixy, Inc.), Amendment and Exchange Agreement (ShiftPixy, Inc.), Amendment and Exchange Agreement (ShiftPixy, Inc.)

Authorized and Outstanding Capital Stock. As of the date hereof, the authorized capital stock of the Company consists of (A) 300,000,000 250,000,000 shares of Common Stock, of which, 46,383,143 26,805,270 are issued and outstanding and (B) 50,000,000 0 shares of Preferred Stock, none of which are issued and outstandingpreferred stock.

Appears in 2 contracts

Samples: Securities Purchase Agreement (Cantabio Pharmaceuticals Inc.), Securities Purchase Agreement (Cantabio Pharmaceuticals Inc.)

Authorized and Outstanding Capital Stock. As of the date hereof, the The Company’s authorized capital stock of the Company consists of (A) 300,000,000 250,000,000 shares of Common Stock, and 10,000,000 preferred shares, $0.001 par value. As of which, 46,383,143 are the Reference Date there were 45,115,181 shares of our common stock issued and outstanding and (B) 50,000,000 no shares of Preferred Stock, none preferred stock issued and outstanding. If all of which the Offered Shares are sold there will be an aggregate of 47,615,181 shares of Common Stock issued and outstanding.

Appears in 2 contracts

Samples: Subscription Agreement (Power of the Dream Ventures Inc), Subscription Agreement (Power of the Dream Ventures Inc)

Authorized and Outstanding Capital Stock. As of the date hereof, the authorized capital stock of the Company consists of (A) 300,000,000 100,000,000 ordinary shares, $0.0001 par value, comprising 98,000,000 Class A ordinary shares of Common Stockand 2,000,000 Class B ordinary shares, of which, 46,383,143 are issued which 12,624,371 Class A ordinary shares and outstanding and (B) 50,000,000 2,000,000 Class B ordinary shares of Preferred Stock, none of which are issued and outstanding.

Appears in 2 contracts

Samples: Standby Equity Purchase Agreement (Powell Max LTD), Standby Equity Purchase Agreement (Powell Max LTD)

Authorized and Outstanding Capital Stock. As of the date hereof, the authorized capital stock of the Company consists of of: (Ai) 300,000,000 preferred stock, $0.01 par value per share, 20,000 authorized shares of Common Stock, of which, 46,383,143 are and 8,760 shares issued and outstanding outstanding, and (Bii) 50,000,000 common stock, $0.01 par value per share, 80,000,000 authorized shares of Preferred Stock, none of which are and 5,436,629 issued and outstanding.

Appears in 2 contracts

Samples: Standby Equity Purchase Agreement (Intrusion Inc), Standby Equity Purchase Agreement (Intrusion Inc)

Authorized and Outstanding Capital Stock. As of the date hereof, the authorized capital stock of the Company consists of 150,000,000 shares, of which 100,000,000 shares are common stock, $0.0001 par value, and 50,000,000 shares are preferred stock, $0.0001 par value per share (A) 300,000,000 the “Preferred Stock”). As of the date hereof, there are 30,990,847 shares of Common Stock, of which, 46,383,143 are issued Stock and outstanding and (B) 50,000,000 no shares of Preferred Stock, none of which are Stock issued and outstanding.

Appears in 2 contracts

Samples: Standby Equity Purchase Agreement (GameSquare Holdings, Inc.), Standby Equity Purchase Agreement (GameSquare Holdings, Inc.)

Authorized and Outstanding Capital Stock. As of the date hereofEffective Date, the authorized capital stock of the Company consists of (A) 300,000,000 400,000,000 shares of Common Stock, of which, 46,383,143 which 20,757,541 are issued and outstanding and (B) 50,000,000 15,000,000 shares of Preferred Stock, none of which 6,000 shares are issued designated as the Series A Convertible Preferred Stock, of which no shares are outstanding and one share is designated as the Series B Preferred Stock, of which no shares are outstanding. No shares of Common Stock are held in the treasury of the Company.

Appears in 1 contract

Samples: Securities Purchase Agreement (Verb Technology Company, Inc.)

Authorized and Outstanding Capital Stock. As of the date hereof, the authorized capital stock of the Company consists of (A) 300,000,000 5,500,000,000 shares of Common StockClass A common stock, $0.0001 par value, of which, 46,383,143 which 14,323,764 are issued and outstanding outstanding, and (B) 50,000,000 3,250,000,000 shares of Preferred StockClass V common stock, none $0.0001 par value, of which 124,253,176 are issued and outstanding.

Appears in 1 contract

Samples: Standby Equity Purchase Agreement (MSP Recovery, Inc.)

Authorized and Outstanding Capital Stock. As of the date hereof, the The authorized capital ---------------------------------------- stock of the Company consists of (A) 300,000,000 1,000,000 shares of Common Stockcommon stock, $.01 par value per share, of which, 46,383,143 are which 59,056 shares have been issued and outstanding and (B) 50,000,000 shares of Preferred Stock, none of which are issued and outstanding.

Appears in 1 contract

Samples: Merger Agreement (Hudson Respiratory Care Inc)

Authorized and Outstanding Capital Stock. As of the date hereof, the authorized capital stock of the Company consists of (A) 300,000,000 shares of Common Stock, of which, 46,383,143 9,614,743 are issued and outstanding and (B) 50,000,000 100,000,000 shares of Preferred Stockpreferred stock, par value $0.00001 per share, none of which are issued and outstanding.

Appears in 1 contract

Samples: Securities Purchase Agreement (Cardio Diagnostics Holdings, Inc.)

Authorized and Outstanding Capital Stock. As of the date hereof, the authorized capital stock of the Company consists of (A) 300,000,000 1,000,000,000 (1 billion) shares of Common Stock, of which, 46,383,143 4,681,399 (four million, six hundred eighty-one thousand three hundred ninety-nine) are issued and outstanding and (B) 50,000,000 20,000,000 (twenty million) shares of Preferred Stock, none of which are issued and outstanding.

Appears in 1 contract

Samples: Securities Purchase Agreement (Top Ships Inc.)

Authorized and Outstanding Capital Stock. As of the date hereof, the authorized capital stock of the Company consists of (A) 300,000,000 1,000,000,000 shares of Common Stock, of which, 46,383,143 166,079,676 are issued and outstanding and (B) 50,000,000 10,000,000 shares of Preferred Stock, none of which are issued and outstanding.

Appears in 1 contract

Samples: Securities Purchase Agreement (Xos, Inc.)

Authorized and Outstanding Capital Stock. As of the date hereof, the authorized capital stock of the Company consists of (A) 300,000,000 100,000,000 shares of Common Stockcommon stock, $0.00001 par value, of which, 46,383,143 are issued and outstanding and (B) 50,000,000 which 41,634,000 shares of Preferred Stock, none of which common stock are issued and outstanding.

Appears in 1 contract

Samples: Standby Equity Purchase Agreement (Armlogi Holding Corp.)

Authorized and Outstanding Capital Stock. As of the date Effective Date hereof, the authorized capital stock of the Company consists of (A) 300,000,000 500,000 shares of Class A Voting Common Stock, of which, 46,383,143 1,000 are issued and outstanding and outstanding; (B) 50,000,000 500,000 shares of Preferred Class B Non- Voting Common Stock, none of which 0 shares are issued and outstanding.

Appears in 1 contract

Samples: Securities Purchase Agreement (Magnegas Applied Technology Solutions, Inc.)

Authorized and Outstanding Capital Stock. As of the date hereof, the authorized capital stock of the Company consists of (A) 300,000,000 730,000,000 shares of Class A Common Stock, of which$0.0001 par value, 46,383,143 are issued and outstanding and (B) 50,000,000 shares of Preferred Stock, none of which 21,782,861 are issued and outstanding.

Appears in 1 contract

Samples: Standby Equity Purchase Agreement (Celularity Inc)

Authorized and Outstanding Capital Stock. As of the date hereof, the authorized capital stock of the Company consists of (A) 300,000,000 80,000,000 shares of Common Stockcommon stock, $0.0001 par value, of which, 46,383,143 are issued and outstanding and (B) 50,000,000 shares of Preferred Stock, none of which 17,346,871 are issued and outstanding.

Appears in 1 contract

Samples: Standby Equity Purchase Agreement (Spectral AI, Inc.)

Authorized and Outstanding Capital Stock. As of the date Effective Date hereof, the authorized capital stock of the Company consists of (A) 300,000,000 10,000 shares of Common Stock, of which, 46,383,143 are issued and outstanding and (B) 50,000,000 shares of Preferred Stock, none of which 6,000 are issued and outstanding. All of the share of Common Stock outstanding are owned, collectively, by the Sellers.

Appears in 1 contract

Samples: Securities Purchase Agreement (Magnegas Corp)

Authorized and Outstanding Capital Stock. As of the date hereof, the authorized capital stock of the Company consists of (A) 300,000,000 70,000,000 shares of Common Stock, of which, 46,383,143 10,694,844 are issued and outstanding and 3,192,719 shares are reserved for issuance pursuant to Convertible Securities (as defined below) exercisable or exchangeable for, or convertible into, shares of Common Stock and (B) 50,000,000 2,000,000 shares of Preferred Stock, none of which are issued and outstanding. No shares of Common Stock are held in the treasury of the Company.

Appears in 1 contract

Samples: Securities Purchase Agreement (Annovis Bio, Inc.)

Authorized and Outstanding Capital Stock. As of the date hereof, the authorized capital stock of the Company consists of (A) 300,000,000 200,000,000 shares of Common Stock, of which, 46,383,143 36,566,651 are issued and outstanding and (B) 50,000,000 no shares of Preferred Common Stock are reserved for issuance pursuant to Convertible Securities (as defined below) (other than the Existing Notes, the Existing Warrants, the Notes and the Warrants) exercisable or exchangeable for, or convertible into, shares of Common Stock, none . No shares of which Common Stock are issued and outstandingheld in the treasury of the Company.

Appears in 1 contract

Samples: Securities Purchase Agreement (BIMI International Medical Inc.)

Authorized and Outstanding Capital Stock. As of the date hereofof this Agreement, the authorized capital stock of the Company consists of (A) 300,000,000 500,000,000 shares of Common Stock, of which, 46,383,143 [ ] are issued and outstanding and [ ] shares are reserved for issuance pursuant to Convertible Securities (Bas defined below) 50,000,000 (other than the Note and Warrant) exercisable or exchangeable for, or convertible into, shares of Preferred Common Stock, none of which are issued and outstanding.

Appears in 1 contract

Samples: Securities Purchase Agreement (Noco-Noco Inc.)

Authorized and Outstanding Capital Stock. As of the date hereof, the authorized capital stock of the Company consists of (A) 300,000,000 250,000,000 shares of Common Stock, of which, 46,383,143 53,493,214 are issued and outstanding and (B) 50,000,000 0 shares of Preferred Stock, none of which are issued and outstandingpreferred stock.

Appears in 1 contract

Samples: Securities Purchase Agreement (Cantabio Pharmaceuticals Inc.)

Authorized and Outstanding Capital Stock. As of the date hereof, the authorized capital stock of the Company consists of (A) 300,000,000 2,000,000,000 shares of Common Stock, of which, 46,383,143 334,919,914 shares are issued and outstanding and (B) 50,000,000 25,000,000 shares of Preferred Stock, none of which are issued and outstanding.

Appears in 1 contract

Samples: Securities Purchase Agreement (Virgin Orbit Holdings, Inc.)

Authorized and Outstanding Capital Stock. As of the date hereof, the authorized capital stock of the Company consists of (A) 300,000,000 1,000,000,000 shares of Common Stock, of which, 46,383,143 which 23,451,179 shares are issued and outstanding and, except as set forth on Schedule 3(m)(iii), no shares are reserved for issuance pursuant to Convertible Securities (as defined below) exercisable or exchangeable for, or convertible into, shares of Common Stock, and (B) 50,000,000 20,000,000 shares of Preferred Stock, none of which are issued and outstandingissued, outstanding or otherwise reserved for issuance.

Appears in 1 contract

Samples: Securities Purchase Agreement (Ipsidy Inc.)

Authorized and Outstanding Capital Stock. As of the date hereof, the authorized capital stock of the Company consists of (A) 300,000,000 500,000,000 shares of Common Stock, of which, 46,383,143 79,310,249 are issued and outstanding and (B) 50,000,000 144,206 shares are held in the treasury of Preferred Stock, none of which are issued and outstandingthe Company.

Appears in 1 contract

Samples: Securities Purchase Agreement (CBAK Energy Technology, Inc.)

Authorized and Outstanding Capital Stock. As of the date hereof, the authorized capital stock of the Company consists of (A) 300,000,000 100,000,000 shares of Common Stock, of which, 46,383,143 54,123,603 are issued and outstanding outstanding, 1,920,944 shares are reserved for make-good shares’ issuance and 3,900,000 shares are reserved for the exercise of options and (B) 50,000,000 10,000,000 shares of Preferred Stock, none of which are issued and outstanding.. 487,155 shares of Common Stock are held in the treasury of the Company

Appears in 1 contract

Samples: Securities Purchase Agreement (Kandi Technologies Group, Inc.)

Authorized and Outstanding Capital Stock. As of the date hereof, the authorized capital stock of the Company consists of (A) 300,000,000 500,000,000 shares of Common Stock, of which, 46,383,143 117,065,675 are issued and outstanding and (B) 50,000,000 shares of Preferred Stock, none of which are issued and outstanding. The Company also has 500,000 Warrants and 930,000 options issued and outstanding.

Appears in 1 contract

Samples: Securities Purchase Agreement (Nascent Biotech Inc.)

Authorized and Outstanding Capital Stock. As of the date Effective Date hereof, the authorized capital stock of the Company consists of (A) 300,000,000 100,000 shares of Common Stock, of which, 46,383,143 are issued and outstanding and (B) 50,000,000 shares of Preferred Stock, none of which 10,000 are issued and outstanding.

Appears in 1 contract

Samples: Securities Purchase Agreement (Taronis Technologies, Inc.)

Authorized and Outstanding Capital Stock. As of the date hereof, the authorized capital stock of the Company consists of (A) 300,000,000 250,000,000 shares of Common Stock, of which, 46,383,143 13,987,130 are issued and outstanding and (B) 50,000,000 100,000,000 shares of Preferred Stock, none of which are issued and outstanding.

Appears in 1 contract

Samples: Securities Purchase Agreement (Q BioMed Inc.)

Authorized and Outstanding Capital Stock. As of the date hereof, the authorized capital stock of the Company consists of 101,000,000 shares each with a par value of $0.0001 par value, consisting of (Ai) 300,000,000 100,000,000 shares of Common Stock, and (ii) 1,000,000 shares of which, 46,383,143 preferred stock. As of the date hereof 23,850,010 shares of common stock are issued and outstanding outstanding, and (B) 50,000,000 no shares of Preferred Stock, none of which preferred stock are issued and outstanding.

Appears in 1 contract

Samples: Standby Equity Purchase Agreement (OneMedNet Corp)

Authorized and Outstanding Capital Stock. As of the date hereof, the The Company’s authorized capital stock of the Company consists of (A) 300,000,000 250,000,000 shares of Common Stock, and 10,000,000 preferred shares, $0.001 par value. As of which, 46,383,143 are the Reference Date there were ______________ shares of our common stock issued and outstanding and (B) 50,000,000 no shares of Preferred Stock, none preferred stock issued and outstanding. If all of which the Offered Shares are sold there will be an aggregate of ________________ shares of Common Stock issued and outstanding.

Appears in 1 contract

Samples: Subscription Agreement (Power of the Dream Ventures Inc)

Authorized and Outstanding Capital Stock. As of the date hereof, the authorized capital stock of the Company consists of (A) 300,000,000 1,500,000,000 shares of Common Stock, of which, 46,383,143 which 133,871,256 shares are issued and outstanding (and of which none are reserved for issuance) and (B) 50,000,000 shares of Preferred Stockpreferred stock, none of which 7,000,000 shares of Series A Convertible Redeemable Preferred Stock are issued and outstanding.

Appears in 1 contract

Samples: Securities Purchase Agreement (Ideanomics, Inc.)

Authorized and Outstanding Capital Stock. As of the date hereof, the authorized capital stock of the Company consists of (A) 300,000,000 500,000,000 shares of common stock, $0.01 par value, and 50,000,000 shares of preferred stock, par value $0.01, of which 50,000 shares are designated as Series D convertible preferred stock. As of the date hereof 20,991,723 shares of Common Stock, of which, 46,383,143 are issued and outstanding and (B) 50,000,000 16,507 shares of Preferred Stock, none of which are issued and outstandingSeries D convertible preferred stock.

Appears in 1 contract

Samples: Standby Equity Purchase Agreement (Prairie Operating Co.)

Authorized and Outstanding Capital Stock. As of the date Effective Date hereof, the authorized capital stock of the Company Corporation consists of (A) 300,000,000 1,000,000 shares of Common Stock, of which, 46,383,143 are issued and outstanding and (B) 50,000,000 shares of Preferred Stock, none of which 100 are issued and outstanding.

Appears in 1 contract

Samples: Securities Purchase Agreement (Magnegas Applied Technology Solutions, Inc.)

Authorized and Outstanding Capital Stock. As of the date hereof, the authorized capital stock of the Company consists of (A) 300,000,000 70,000,000 Class A ordinary shares with a par value of Common Stock$0.01 per share, of which, 46,383,143 9,157,660 are issued and outstanding and (B) 50,000,000 30,000,000 Class B ordinary shares with a par value of Preferred Stock$0.01 per share, none of which which, 2,863,100 are issued and outstanding.

Appears in 1 contract

Samples: Securities Purchase Agreement (AnPac Bio-Medical Science Co., Ltd.)

Authorized and Outstanding Capital Stock. As of the date hereof, the authorized capital stock of the Company consists of (A) 300,000,000 shares of Common StockOrdinary Shares, of which, 46,383,143 are issued and outstanding and (B) 50,000,000 which 139,885,532 shares of Preferred Stock, none of which are issued and outstanding.

Appears in 1 contract

Samples: Securities Purchase Agreement (Therapix Biosciences Ltd.)

Authorized and Outstanding Capital Stock. As of the date hereof, the authorized capital stock of the Company consists of (A) 300,000,000 250,000,000 shares of Common Stock, of which, 46,383,143 28,993,430 are issued and outstanding and (B) 50,000,000 0 shares of Preferred Stock, none of which are issued and outstandingpreferred stock.

Appears in 1 contract

Samples: Securities Purchase Agreement (Cantabio Pharmaceuticals Inc.)

Authorized and Outstanding Capital Stock. As of the date hereof, the authorized capital stock of the Company consists of (A) 300,000,000 1,000,000,000 shares of Common Stock, of which, 46,383,143 567,343,873 are issued and outstanding and (B) 50,000,000 10,000,000 shares of Preferred Stockpreferred stock, none of which are issued and outstanding.

Appears in 1 contract

Samples: Securities Purchase Agreement (Canoo Inc.)

Authorized and Outstanding Capital Stock. As of the date hereof, the authorized capital stock of the Company consists of (A) 300,000,000 1,000,000,000 shares of Common Stock, of which, 46,383,143 70,184,184 are issued and outstanding and (B) 50,000,000 100,000 shares of Preferred Stock, none 15,002 of which are issued and outstanding.

Appears in 1 contract

Samples: Securities Purchase Agreement (Dalrada Financial Corp)

Authorized and Outstanding Capital Stock. As of the date hereof, the authorized capital stock of the Company consists of (A) 300,000,000 1,000,000,000 shares of Common Stock, of which, 46,383,143 477,479,873 are issued and outstanding and (B) 50,000,000 10,000,000 shares of Preferred Stockpreferred stock, none of which are issued and outstanding.

Appears in 1 contract

Samples: Securities Purchase Agreement (Canoo Inc.)

Authorized and Outstanding Capital Stock. As of the date hereof, the authorized capital stock of the Company consists of (A) 300,000,000 shares of Common Stock350,000,000 authorized Class A Ordinary Shares, of which, 46,383,143 which 334,099,682 are issued and outstanding and outstanding, (B) 50,000,000 shares 350,000,000 authorized Class B Ordinary Shares, of Preferred Stockwhich 54,819,733 are issued and outstanding, and (C) 100,000,000 Golden Shares, none of which are issued and outstanding.

Appears in 1 contract

Samples: Securities Purchase Agreement (Molecular Data Inc.)

Authorized and Outstanding Capital Stock. As of the date hereof, the authorized capital stock of the Company consists of (A) 300,000,000 5,000,000,000 shares of Common StockOrdinary Shares, $0.4 par value, of which, 46,383,143 are issued and outstanding and (B) 50,000,000 shares of Preferred Stock, none of which 259,824,578 are issued and outstanding.

Appears in 1 contract

Samples: Standby Equity Purchase Agreement (X3 Holdings Co., Ltd.)

Authorized and Outstanding Capital Stock. As of the date hereof, the authorized capital stock of the Company consists of (A) 300,000,000 150,000,000 shares of Common Stockcommon stock, $0.0001 par value, of which, 46,383,143 are issued and outstanding and (B) 50,000,000 shares of Preferred Stock, none of which 46,148,386 are issued and outstanding.

Appears in 1 contract

Samples: Standby Equity Purchase Agreement (Sadot Group Inc.)

Authorized and Outstanding Capital Stock. As of the date hereof, the authorized capital stock of the Company consists of (A) 300,000,000 250,000,000 shares of Common Stock, of which, 46,383,143 9,167,146 are issued and outstanding and (B) 50,000,000 100,000,000 shares of Preferred Stock, none of which are issued and outstanding.

Appears in 1 contract

Samples: Securities Purchase Agreement (Q BioMed Inc.)

Authorized and Outstanding Capital Stock. As of the date hereof, the authorized capital stock of the Company consists of (A) 300,000,000 265,000,000 shares of Common Stock, of which, 46,383,143 which 107,360,577 are issued and outstanding and 31,752,472 shares are reserved for issuance pursuant to Convertible Securities (as defined below) exercisable or exchangeable for, or convertible into, shares of Common Stock and (B) 50,000,000 10,000,000 shares of Preferred Stock, none of which are issued and outstanding. No shares of Common Stock are held in the treasury of the Company.

Appears in 1 contract

Samples: Second Exchange Agreement (KushCo Holdings, Inc.)

Authorized and Outstanding Capital Stock. As of the date hereof, the authorized capital stock of the Company consists of (A) 300,000,000 1,000,000,000 shares of Common Stock, of which, 46,383,143 43,495,861 are issued and outstanding and 73,236,325 shares are reserved for issuance pursuant to Convertible Securities (as defined below) (other than the Notes and the Warrants) exercisable or exchangeable for, or convertible into, shares of Common Stock and (B) 50,000,000 0 shares of Preferred Stock, none of which are issued and outstanding.

Appears in 1 contract

Samples: Securities Purchase Agreement (Phunware, Inc.)

Authorized and Outstanding Capital Stock. As of the date hereof, the authorized capital stock of the Company consists of (A) 300,000,000 250,000,000 shares of Common Stock, of which, 46,383,143 approximately 11,000,000 are issued and outstanding and (B) 50,000,000 100,000,000 shares of Preferred Stock, none of which are issued and outstanding.

Appears in 1 contract

Samples: Securities Purchase Agreement (Q BioMed Inc.)

Authorized and Outstanding Capital Stock. As of the date hereof, the authorized capital stock of the Company consists of (A) 300,000,000 600,000,000 shares of Common Stock, of which, 46,383,143 which 7,334,395 are issued and outstanding and 1,009,503 shares are reserved for issuance pursuant to Convertible Securities (as defined below) exercisable or exchangeable for, or convertible into, shares of Common Stock and (B) 50,000,000 1,000,000 shares of Preferred Stock, none of which are issued and outstanding. No shares of Common Stock are held in the treasury of the Company.

Appears in 1 contract

Samples: Securities Purchase Agreement (AEye, Inc.)

Authorized and Outstanding Capital Stock. As of the date hereof, the authorized capital stock of the Company consists of of: (Ai) 300,000,000 preferred stock, $0.001 par value per share, 20,000,000 authorized shares of Common Stock, of which, 46,383,143 are and 0 shares issued and outstanding outstanding, and (Bii) 50,000,000 common stock, $0.0001 par value per share, 600,000,000 authorized shares of Preferred Stock, none of which are and 18,547,201 issued and outstanding.

Appears in 1 contract

Samples: Standby Equity Purchase Agreement (Spectaire Holdings Inc.)

Authorized and Outstanding Capital Stock. As of the date hereof, the authorized capital stock of the Company consists of (A) 300,000,000 50,000,000 shares of Common Stock, of which, 46,383,143 9,073,289 are issued and outstanding and 4,527,218 shares are reserved for issuance pursuant to Convertible Securities (Bas defined below) 50,000,000 (other than the Notes and the Warrants) exercisable or exchangeable for, or convertible into, shares of Preferred Common Stock, none . 0 shares of which Common Stock are issued and outstandingheld in the treasury of the Company.

Appears in 1 contract

Samples: Securities Purchase Agreement (BOQI International Medical, Inc.)

Authorized and Outstanding Capital Stock. As of the date hereof, the authorized capital stock of the Company consists of (A) 300,000,000 260,000,000 shares of capital stock, consisting of 250,000,000 shares of Common StockStock and 10,000,000 shares of preferred stock. As of the date hereof, there are 31,692,585 shares of which, 46,383,143 are Common Stock issued and outstanding and (B) 50,000,000 no shares of Preferred Stock, none of which are the Company’s preferred stock issued and outstanding.

Appears in 1 contract

Samples: Second Amendment Agreement (Cryptyde, Inc.)

Authorized and Outstanding Capital Stock. As of the date hereof, the authorized capital stock of the Company consists of (A) 300,000,000 150,000,000 shares of Common Stock, of which, 46,383,143 17,288,116 are issued and outstanding and (B) 50,000,000 20,000,000 shares of Preferred Stock, none of which are issued and outstanding.

Appears in 1 contract

Samples: Securities Purchase Agreement (Treasure Global Inc)

Authorized and Outstanding Capital Stock. As of the date hereof, the authorized capital stock of the Company consists of (A) 300,000,000 an unlimited number of shares of Common Stockcommon stock, no par value, of which, 46,383,143 are issued and outstanding and (B) 50,000,000 shares of Preferred Stock, none of which 197,462,832 are issued and outstanding.

Appears in 1 contract

Samples: Securities Purchase Agreement (Tanzanian Gold Corp)

AutoNDA by SimpleDocs

Authorized and Outstanding Capital Stock. As of the date hereof, the authorized capital stock of the Company consists of (A) 300,000,000 shares of Common Stock550,000,000 authorized Class A Ordinary Shares, of which, 46,383,143 which 390,800,736 are issued and outstanding outstanding, and (B) 50,000,000 shares of Preferred Stock350,000,000 authorized Class B Ordinary Shares, none of which 54,819,733 are issued and outstanding.

Appears in 1 contract

Samples: Securities Purchase Agreement (Molecular Data Inc.)

Authorized and Outstanding Capital Stock. As of the date hereof, the authorized capital stock of the Company consists of (A) 300,000,000 Unlimited shares of Class A Common Stock, of which, 46,383,143 927,378,166 are issued and outstanding (B) unlimited shares of Class B Common Stock, of which, 0 are issued and outstanding and (BC) 50,000,000 an Unlimited number of shares of Class A Preferred Stock, none of which 2 are issued and outstandingoutstanding1.

Appears in 1 contract

Samples: Securities Purchase Agreement (Kraig Biocraft Laboratories, Inc)

Authorized and Outstanding Capital Stock. As of the date hereof, the authorized capital stock of the Company consists of (A) 300,000,000 500,000,000 shares of Common Stock, of which, 46,383,143 66,628,158 are issued and outstanding and (B) 50,000,000 144,206 shares are held in the treasury of Preferred Stock, none of which are issued and outstandingthe Company.

Appears in 1 contract

Samples: Securities Purchase Agreement (CBAK Energy Technology, Inc.)

Authorized and Outstanding Capital Stock. As of the date hereof, the authorized capital stock of the Company consists of (A) 300,000,000 shares of Common Stock500,000,000 ordinary shares, of which, 46,383,143 which 59,893,327 ordinary shares are issued and outstanding and (B) 50,000,000 shares of Preferred Stock, none of which are issued and outstanding.

Appears in 1 contract

Samples: Standby Equity Purchase Agreement (Zapp Electric Vehicles Group LTD)

Authorized and Outstanding Capital Stock. As of the date hereof, the authorized capital stock of the Company consists of (A) 300,000,000 250,000,000 shares of Common Stock, of which, 46,383,143 22,468,185 are issued and outstanding and outstanding, (B) 50,000,000 500,000 Series A Preferred Shares, none of which are issued and outstanding, (C) 1,000,000 Series B Preferred Shares, none of which are issued and outstanding, and (E) 98,500,000 shares of Preferred Stockblank check preferred stock, none of which are issued and outstanding.

Appears in 1 contract

Samples: Securities Purchase Agreement (Q BioMed Inc.)

Authorized and Outstanding Capital Stock. As of the date hereofSeptember 26, 2023, the authorized capital stock of the Company consists of (A) 300,000,000 1,000,000,000 shares of Common Stock, of which, 46,383,143 643,268,500 are issued and outstanding and (B) 50,000,000 10,000,000 shares of Preferred Stockpreferred stock, none of which are issued and outstanding.

Appears in 1 contract

Samples: Securities Purchase Agreement (Canoo Inc.)

Authorized and Outstanding Capital Stock. As of the date hereof, the authorized capital stock of the Company consists of (A) 300,000,000 100,000,000 shares of Common Stock, of which, 46,383,143 25,789,400 are issued and outstanding and no shares are reserved for issuance pursuant to Convertible Securities (as defined below) (other than the Common Shares and the Warrants) exercisable or exchangeable for, or convertible into, shares of Common Stock and (B) 50,000,000 no shares of Preferred Stock, none . No shares of which Common Stock are issued and outstandingheld in the treasury of the Company.

Appears in 1 contract

Samples: Securities Purchase Agreement (Senmiao Technology LTD)

Authorized and Outstanding Capital Stock. As of the date hereof, the authorized capital stock of the Company consists of (A) 300,000,000 250,000,000 shares of Common Stock, of which, 46,383,143 23,410,573 are issued and outstanding and (B) 50,000,000 100,000,000 shares of Preferred Stock, none of which are issued and outstanding.

Appears in 1 contract

Samples: Securities Purchase Agreement (Q BioMed Inc.)

Authorized and Outstanding Capital Stock. As of the date hereof, the authorized capital stock of the Company consists of (A) 300,000,000 100,000,000 shares of Common Stock, of which, 46,383,143 which 1,248,918 are issued and outstanding and (B) 50,000,000 3,000,000 shares of Preferred Stock, none of which are issued and outstanding. 51 shares of Common Stock are held in the treasury of the Company.

Appears in 1 contract

Samples: Exchange Agreement (Aditxt, Inc.)

Authorized and Outstanding Capital Stock. As of the date hereof, the authorized capital stock of the Company consists of (A) 300,000,000 265,000,000 shares of Common Stock, of which, 46,383,143 which 127,274,667 are issued and outstanding and 36,736,880 shares are reserved for issuance pursuant to Convertible Securities (as defined below) exercisable or exchangeable for, or convertible into, shares of Common Stock and (B) 50,000,000 10,000,000 shares of Preferred Stock, none of which are issued and outstanding. No shares of Common Stock are held in the treasury of the Company.

Appears in 1 contract

Samples: Fourth Exchange Agreement (KushCo Holdings, Inc.)

Authorized and Outstanding Capital Stock. As of the date hereof, the authorized capital stock of the Company consists of (A) 300,000,000 250,000,000 shares of Common Stock, of which, 46,383,143 approximately [------------] are issued and outstanding and (B) 50,000,000 100,000,000 shares of Preferred Stock, none of which there are authorized 500,000 shares of Class A Convertible Preferred Stock (227,998 are outstanding) and 1,000,000 shares of Class B Convertible Preferred Stock (503,134 are outstanding) are issued and outstanding.

Appears in 1 contract

Samples: Securities Purchase Agreement (Q BioMed Inc.)

Authorized and Outstanding Capital Stock. As of the date hereof, the authorized capital stock of the Company consists of (A) 300,000,000 shares of Common Stock70,000,000 Class A Ordinary Shares, of which, 46,383,143 which 11,340,476 are issued and outstanding and (B) 50,000,000 30,000,000 Class B ordinary shares with a par value of Preferred StockUS$0.01 per share, none of which 2,773,100 are issued and outstanding.

Appears in 1 contract

Samples: Securities Purchase Agreement (AnPac Bio-Medical Science Co., Ltd.)

Authorized and Outstanding Capital Stock. As of the date hereof, the authorized capital stock of the Company consists of (A) 300,000,000 50,000,000 ordinary shares with a par value of Common Stock$0.01 per share, of which, 46,383,143 are issued and outstanding and (B) 50,000,000 shares of Preferred Stock, none of which 23,894,027 are issued and outstanding.

Appears in 1 contract

Samples: Securities Purchase Agreement (China Xiangtai Food Co., Ltd.)

Authorized and Outstanding Capital Stock. As of the date hereof, the authorized capital stock of the Company consists of (A) 300,000,000 200,000,000 shares of Common Stock, of which, 46,383,143 68,232,409 are issued and outstanding and 24,817,872 shares are reserved for issuance pursuant to Convertible Securities (as defined below) exercisable or exchangeable for, or convertible into, shares of Common Stock and (B) 50,000,000 10,000,000 shares of Preferred Stock, none of which are issued and outstanding. No shares of Common Stock are held in the treasury of the Company.

Appears in 1 contract

Samples: Securities Purchase Agreement (Ampio Pharmaceuticals, Inc.)

Authorized and Outstanding Capital Stock. As of the date hereof, the authorized capital stock of the Company consists of (A) 300,000,000 100,000,000 shares of Common Stock, of which, 46,383,143 9,564,001 are issued and outstanding and (B) 50,000,000 1,000,000 shares of Preferred Stockpreferred stock, none of which are issued and outstanding.

Appears in 1 contract

Samples: Standby Equity Purchase Agreement (GigCapital5, Inc.)

Authorized and Outstanding Capital Stock. As of the date hereof, the authorized capital stock of the Company consists of (A) 300,000,000 350,000,000 shares of Common Stock, of which, 46,383,143 which 97,543,028 are issued and outstanding and (B) 50,000,000 10,000,000 shares of Preferred Stockpreferred stock, none of which none are issued and outstanding.

Appears in 1 contract

Samples: Securities Purchase Agreement (Airborne Wireless Network)

Authorized and Outstanding Capital Stock. As of the date hereof, the authorized capital stock of the Company consists of (A) 300,000,000 250,000,000 shares of Common Stock, of which, 46,383,143 16,720,871 are issued and outstanding and (B) 50,000,000 100,000,000 shares of Preferred Stock, none of which are issued and outstanding.

Appears in 1 contract

Samples: Securities Purchase Agreement (Q BioMed Inc.)

Authorized and Outstanding Capital Stock. As of the date hereofAugust 14, 2020, the authorized capital stock of the Company consists of (A) 300,000,000 100,000,000 shares of Common Stock, of which, 46,383,143 23,054,474 are issued and outstanding and 4,592,058 shares are reserved for issuance pursuant to Convertible Securities (B) 50,000,000 as defined below exercisable or exchangeable for, or convertible into, shares of Preferred Common Stock, none . No shares of which Common Stock are issued and outstandingheld in the treasury of the Company.

Appears in 1 contract

Samples: Securities Purchase Agreement (ONCOSEC MEDICAL Inc)

Authorized and Outstanding Capital Stock. As of the date hereof, the authorized capital stock of the Company consists of (A) 300,000,000 265,000,000 shares of Common Stock, of which, 46,383,143 which 119,998,767 are issued and outstanding and 39,736,880 shares are reserved for issuance pursuant to Convertible Securities (as defined below) exercisable or exchangeable for, or convertible into, shares of Common Stock and (B) 50,000,000 10,000,000 shares of Preferred Stock, none of which are issued and outstanding. No shares of Common Stock are held in the treasury of the Company.

Appears in 1 contract

Samples: Third Exchange Agreement (KushCo Holdings, Inc.)

Authorized and Outstanding Capital Stock. As of the date hereof, the authorized capital stock of the Company consists of (A) 300,000,000 shares of 100,000,000 Common Stock, of which, 46,383,143 are issued Shares and outstanding and (B) 50,000,000 5,000,000 shares of Preferred Stock, none par value $0.0001 per share, (the “Preferred Stock”), of which 18,540,474 Common Shares are issued and outstanding, and none of the Preferred Stock have been designated or issued.

Appears in 1 contract

Samples: Securities Purchase Agreement (Us Nuclear Corp.)

Authorized and Outstanding Capital Stock. As of the date hereofof this Agreement, the authorized capital stock of the Company consists of (A) 300,000,000 100,000,000 shares of Common Stock, of which, 46,383,143 16,783,631 are issued and outstanding and 960,000 shares are reserved for issuance pursuant to Convertible Securities (as defined below) (other than the Notes and Warrants) exercisable or exchangeable for, or convertible into, shares of Common Stock and (B) 50,000,000 10,000,000 shares of Preferred Stock, none of which 500,000 shares of Preferred Stock are issued and outstanding.

Appears in 1 contract

Samples: Securities Purchase Agreement (Grove, Inc.)

Authorized and Outstanding Capital Stock. As of the date hereof, the authorized capital stock of the Company consists of (A) 300,000,000 250,000,000 shares of Common Stock, of which, 46,383,143 20,252,399 are issued and outstanding and (B) 50,000,000 100,000,000 shares of Preferred Stock, none of which are issued and outstanding.

Appears in 1 contract

Samples: Securities Purchase Agreement (Q BioMed Inc.)

Authorized and Outstanding Capital Stock. As of the date hereof, the authorized capital stock of the Company consists of (Ai) 300,000,000 75,000,000 shares of Common Stockcommon stock, $0.001 par value, of which, 46,383,143 which 5,755,187 are issued and outstanding and (Bii) 50,000,000 6,040,000 shares of Series A Cumulative Perpetual Preferred Stock, none of which 4,953,545 are issued and outstanding, and 187,500 of Series B Convertible Preferred Stock, $0.001 par value, of which 187,500 shares are issued and outstanding.

Appears in 1 contract

Samples: Standby Equity Purchase Agreement (Soluna Holdings, Inc)

Authorized and Outstanding Capital Stock. As of the date hereof, the authorized capital stock of the Company consists of (A) 300,000,000 500,000,000 shares of Common Stock, of which, 46,383,143 117,065,675 are issued and outstanding and (B) 50,000,000 shares of Preferred Stock, none of which are issued and outstanding. The Company also has 1,250,000 Warrants and 930,000 options issued and outstanding.

Appears in 1 contract

Samples: Securities Purchase Agreement (Nascent Biotech Inc.)

Authorized and Outstanding Capital Stock. As of the date hereof, the authorized capital stock of the Company consists of (A) 300,000,000 190,000,000 shares of Common Stock, of which, 46,383,143 which 24,674,425 are issued and outstanding and (B) 50,000,000 10,000,000 shares of Preferred Stockpreferred stock, none of which none are issued and outstanding.

Appears in 1 contract

Samples: Securities Purchase Agreement (Taronis Technologies, Inc.)

Authorized and Outstanding Capital Stock. As of the date hereof, the authorized capital stock of the Company consists of (A) 300,000,000 75,000,000 shares of Common Stock, of which, 46,383,143 1,951,638 are issued and outstanding and (B) 50,000,000 25,000,000 shares of Preferred Stockpreferred stock, none of which are issued and outstanding.

Appears in 1 contract

Samples: Securities Purchase Agreement (Kidpik Corp.)

Authorized and Outstanding Capital Stock. As of the date Effective Date hereof, the authorized capital stock of the Company consists of (A) 300,000,000 1,000 shares of Common Stock, of which, 46,383,143 are issued and outstanding and (B) 50,000,000 shares of Preferred Stock, none of which 650 are issued and outstanding.

Appears in 1 contract

Samples: Securities Purchase Agreement (Magnegas Applied Technology Solutions, Inc.)

Authorized and Outstanding Capital Stock. As of the date hereof, the authorized capital stock of the Company consists of (A) 300,000,000 250,000,000 shares of Common Stock, of which, 46,383,143 25,809,400 are issued and outstanding and (B) 50,000,000 100,000,000 shares of Preferred Stock, none of which 227,998 shares of Series A Preferred Stock and 400,000 shares of Series B Preferred Stock are issued and outstanding.

Appears in 1 contract

Samples: Securities Purchase Agreement (Q BioMed Inc.)

Authorized and Outstanding Capital Stock. As of the date hereof, the authorized capital stock of the Company consists of (A) 300,000,000 shares of Common Stock45,000,000 Ordinary Shares, of which, 46,383,143 15,293,870 are issued and outstanding and (B) 50,000,000 5,000,000 shares of Preferred Stockpreferred stock, none of which are issued and outstanding.

Appears in 1 contract

Samples: Pre Paid Advance Agreement (Mainz Biomed N.V.)

Authorized and Outstanding Capital Stock. As of the date hereof, the authorized capital stock of the Company consists of (A) 300,000,000 1,500,000,000 shares of Common Stock, of which, 46,383,143 which 1,090,266,844 are issued and outstanding (of which issued and outstanding 2,750,000 are reserved for issuance) and (B) 50,000,000 shares of Preferred Stockpreferred stock, none of which none are issued and outstanding.

Appears in 1 contract

Samples: Securities Purchase Agreement (Gulfslope Energy, Inc.)

Authorized and Outstanding Capital Stock. As of the date hereof, the authorized capital stock of the Company consists of (A) 300,000,000 110,000,000 shares of Common Stockcommon stock, $0.0001 par value, of which, 46,383,143 which (i) 8,041,268 Series A common stock are issued and outstanding (which is inclusive of the Series A common stock underlying 4,561 initial public offering units currently outstanding) and (Bii) 50,000,000 shares of Preferred Stock, none of which are one (1) Series B common stock is issued and outstanding. There are also 15,000,000 public warrants and 13,850,000 private warrants outstanding.

Appears in 1 contract

Samples: Standby Equity Purchase Agreement (Atlantic Coastal Acquisition Corp. II)

Authorized and Outstanding Capital Stock. As of the date hereof, the authorized capital stock of the Company consists of (A) 300,000,000 150,000,000 shares of Common Stockcommon stock, $0.0001 par value, and 10,000,000 shares of preferred stock, par value $0.0001 par value per share, of which, 46,383,143 which (i) 41,118,593 shares of common stock are issued and outstanding as of the date of this Agreement and (Bii) 50,000,000 5,825 shares of Series A Convertible Preferred Stock, none of which Stock are issued and outstandingoutstanding as of the date of this Agreement.

Appears in 1 contract

Samples: Standby Equity Purchase Agreement (Coeptis Therapeutics Holdings, Inc.)

Authorized and Outstanding Capital Stock. As of the date hereofJuly 28, 2023, the authorized capital stock of the Company consists of (A) 300,000,000 1,000,000,000 shares of Common Stock, of which, 46,383,143 611,466,726 are issued and outstanding and (B) 50,000,000 10,000,000 shares of Preferred Stockpreferred stock, none of which are issued and outstanding.

Appears in 1 contract

Samples: Securities Purchase Agreement (Canoo Inc.)

Authorized and Outstanding Capital Stock. As of the date hereof, the authorized capital stock of the Company consists of (A) 300,000,000 150,000,000 shares of Common Stockcommon stock, $0.0001 par value, of which, 46,383,143 are issued and outstanding and (B) 50,000,000 shares of Preferred Stock, none of which 3,363,031 are issued and outstanding.

Appears in 1 contract

Samples: Standby Equity Purchase Agreement (Nukkleus Inc.)

Authorized and Outstanding Capital Stock. As of the date hereof, the authorized capital stock of the Company consists of (A) 300,000,000 70,000,000 shares of Common Stock, of which, 46,383,143 10,579,933 are issued and outstanding and 3,192,719 shares are reserved for issuance pursuant to Convertible Securities (as defined below) exercisable or exchangeable for, or convertible into, shares of Common Stock and (B) 50,000,000 2,000,000 shares of Preferred Stock, none of which are issued and outstanding. No shares of Common Stock are held in the treasury of the Company.

Appears in 1 contract

Samples: Securities Purchase Agreement (Annovis Bio, Inc.)

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!